The present study identified the clinical features of the largest multiple endocrine neoplasia type 2 (MEN2) A pedigree from China, with a novel double missense rearranged during transfection (RET) mutation (C634Y/D707E). To the best of our knowledge, the D707E mutation has not been identified to date: In the present study, a total of 101 family members who originated from a large pedigree (134 members in total) underwent RET mutation screening by next-generation sequencing and polymerase chain reaction (PCR) amplification, followed by direct bidirectional DNA sequencing. The clinical features of this pedigree were carefully reviewed retrospectively, and statistical analyses were conducted using SPSS software. A total of 33 (32.67%) carriers were identified to exhibit the C634Y/D707E RET germline mutation. The mean age of the patients with medullary thyroid carcinoma (MTC) identified by RET screening was 38.4 +/- 16.5 years (n=11; range, 14-65 years). Only 4 patients with pheochromocytoma with a median age of 37 years were identified. No. hyperparathyroidism was diagnosed. Persistent or recurrent disease developed in the patients of the present study who underwent inappropriate initial thyroid surgeries that were performed in previous decades (III10, III23, III24, III27 and IV46, as they had undergone two surgeries prior to the present study). A total of 66.70% (6/9) of patients, following thyroidectomy, continued to develop persistent or recurrent disease during the present screening study. In total, 3 patients succumbed to MTC or distant metastasis in the present study. The increase in carcinoembryonic antigen (CEA) levels correlated with the increase in basal serum calcitonin (Ct) levels according to Pearson correlation analysis in patients with MTC without surgery. Ct and CEA levels were also significantly correlated with tumor volumes. To the best of our knowledge, the present study is the first to identify a novel double RET missense mutation in the largest MEN2A pedigree from China. Additional in-depth study is necessary to elucidate the molecular mechanisms of the D707E mutation and its potential joint effects with the other C634Y mutation in the pedigree of the present study.
基金：
Beijing City Health Personnel 'Thou' 100 Level Candidates Project [2012-0053]; Training Project of High-level Medical Technical Personnel in Health System In Beijing City [2013-03-054]
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China[2]Beijing Inst Otolaryngol, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100005, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China[2]Beijing Inst Otolaryngol, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100005, Peoples R China[*1]Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1 Dong Jiao Min Xiang, Dongcheng, Beijing 100730, P.R. China
推荐引用方式(GB/T 7714)：
Lu Fanqian,Chen Xiaohong,Bai Yunlong,et al.A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in RET exon 11[J].ONCOLOGY LETTERS.2017,14(3):3552-3558.doi:10.3892/ol.2017.6583.
APA：
Lu, Fanqian,Chen, Xiaohong,Bai, Yunlong,Feng, Yaru&Wu, Jian.(2017).A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in RET exon 11.ONCOLOGY LETTERS,14,(3)
MLA：
Lu, Fanqian,et al."A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in RET exon 11".ONCOLOGY LETTERS 14..3(2017):3552-3558
